Period Ending | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 |
---|
Total Revenue
|
37,905,000
|
29,321,000
|
23,651,000
| Cost of Revenue | 13,188,000 | 10,417,000 | 8,844,000 | |
Gross Profit
|
24,717,000
|
18,904,000
|
14,807,000
| |
|
Operating Expenses |
|
Research Development | 5,162,000 | 3,762,000 | 2,843,000 |
|
Selling General and Administrative | 7,813,000 | 4,761,000 | 3,652,000 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | |
Operating Income or Loss
|
11,742,000
|
10,381,000
|
8,312,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 584,000 | 415,000 | 69,000 |
|
Earnings Before Interest And Taxes | 12,326,000 | 10,796,000 | 8,381,000 |
|
Interest Expense |
-
|
-
|
-
|
|
Income Before Tax | 12,326,000 | 10,796,000 | 8,381,000 |
|
Income Tax Expense | 2,589,000 | 2,291,000 | 1,861,000 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 9,737,000 | 8,505,000 | 6,520,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
9,737,000
|
8,505,000
|
6,520,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
9,737,000
|
8,505,000
|
6,520,000
|
|